SUMICHEM.NS(SUMICHEM.NS)
SUMICHEM.NS
No analyst ratings available
No analyst price targets available for SUMICHEM.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $35.88B | $40.53B | $45.87B |
| Low | $35.27B | $39.01B | $45.52B |
| High | $36.83B | $41.61B | $46.21B |
| EBITDA Avg | $10.93B | $12.35B | $13.98B |
| Low | $10.75B | $11.89B | $13.87B |
| High | $11.22B | $12.68B | $14.08B |
| EBIT Avg | $9.76B | $11.02B | $12.47B |
| Low | $9.59B | $10.61B | $12.38B |
| High | $10.01B | $11.31B | $12.57B |
| Net Income Avg | $6.21B | $7.27B | $8.93B |
| Low | $6.02B | $6.84B | $8.70B |
| High | $6.73B | $8.07B | $9.17B |
| EPS Avg | $12.72 | $15.02 | $17.90 |
| Low | $12.06 | $13.71 | $17.43 |
| High | $13.49 | $16.18 | $18.37 |
| Analysts (Rev / EPS) | 8 / 9 | 9 / 9 | 2 / 2 |